A bone marrow biopsy supported a diagnosis of B-ALL with the immunophenotype CD10, CD19, CD20 (dim), CD34, CD79a, HLA DR, and TdT+, with a background of dyspoietic myeloid maturation supporting the evolution of EMS to B-ALL. This evidence concerns the gene CD79A and acute lymphoblastic leukemia.